Retirement Systems of Alabama - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Retirement Systems of Alabama ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$16,009,648
+4.2%
178,719
-0.9%
0.08%
+8.7%
Q2 2023$15,360,363
+2.4%
180,413
-0.5%
0.07%
+6.2%
Q1 2023$15,003,899
+4.8%
181,316
-0.4%
0.06%
+4.8%
Q4 2022$14,322,401
+6.0%
182,103
-0.3%
0.06%
-1.6%
Q3 2022$13,517,000
+13.5%
182,584
-0.1%
0.06%
+23.5%
Q2 2022$11,910,000
+3.3%
182,732
+0.1%
0.05%
+21.4%
Q1 2022$11,535,000
+19.3%
182,464
+0.1%
0.04%
+23.5%
Q4 2021$9,670,000
-17.5%
182,321
+9.8%
0.03%
-22.7%
Q3 2021$11,717,000
+11.0%
165,988
+4.8%
0.04%
+15.8%
Q2 2021$10,555,000
-26.3%
158,381
+22.7%
0.04%
-29.6%
Q1 2021$14,324,000
-2.8%
129,035
+4.0%
0.05%
-6.9%
Q4 2020$14,735,000
+36.1%
124,086
-0.0%
0.06%
+16.0%
Q3 2020$10,827,000
-2.2%
124,090
+0.4%
0.05%
-5.7%
Q2 2020$11,074,000
+68.4%
123,649
+87.4%
0.05%
+43.2%
Q1 2020$6,577,000
-13.3%
65,9970.0%0.04%
+8.8%
Q4 2019$7,583,000
-8.9%
65,997
+0.0%
0.03%
-15.0%
Q3 2019$8,325,000
+3.9%
65,996
-0.9%
0.04%
+8.1%
Q2 2019$8,015,000
+38.0%
66,603
+0.3%
0.04%
+32.1%
Q1 2019$5,808,000
-13.4%
66,398
-0.9%
0.03%
-24.3%
Q4 2018$6,705,000
-12.4%
67,012
+0.3%
0.04%
+2.8%
Q3 2018$7,654,000
+26.2%
66,802
-1.2%
0.04%
+20.0%
Q2 2018$6,063,00067,6030.03%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders